Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991068 · ClinicalTrials.gov registry record · Phase 2
Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome
A Phase 2 study, sponsored by ZARS Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00991068: Completed Phase 2 study, sponsored by ZARS Pharma.
NCT00991068 is a Phase 2 study that has completed, run by ZARS Pharma. The registered enrollment target is 24 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00991068, a Phase 2 study, has completed, sponsored by ZARS Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to explore the potential usefulness of Synera for the treatment of pain associated with mild to moderate carpal tunnel syndrome.
Interventions
- DRUG Synera (lidocaine 70 mg and tetracaine 70 mg) topical patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
What the finished NCT00991068 record still lists
NCT00991068 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Synera (lidocaine 70 mg and tetracaine 70 mg) topical patch is the first listed.
NCT00991068 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00991068 about?
NCT00991068 is a clinical study titled "Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome". The purpose of the study is to explore the potential usefulness of Synera for the treatment of pain associated with mild to moderate carpal tunnel syndrome.
What is the current status of trial NCT00991068?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2009-09. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00991068?
The interventions under investigation include: Synera (lidocaine 70 mg and tetracaine 70 mg) topical patch (DRUG).
Who is sponsoring clinical trial NCT00991068?
This trial is sponsored by ZARS Pharma, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00991068's enrollment target sits among peer trials
24 1756th of 2000 higher than 217 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia